Diagnostics

A breakthrough in mycelium-based infection detection has prompted Mushrooms Inc. to halt a merger, betting its future on its own innovative biotech platform.

A new $1.35M program seeks to validate diagnostic tests for Long COVID, paving the way for targeted treatments and offering hope to millions.

A US-Japan biotech firm secures major funding to advance a first-in-class drug, offering new hope for millions with inherited blood disorders.

A new alliance between Discovery Life Sciences and Mindpeak aims to solve inconsistent biomarker interpretation, a critical bottleneck in cancer drug development.

A new platform uses AI to turn complex genetic and lifestyle data into an immediate, actionable cancer prevention plan, shifting the paradigm of care.

A new study claims combining two cheap inflammation tests saves millions by cutting misdiagnoses, challenging years of cost-cutting medical advice.

A rapid sepsis test is proving its worth, slashing mortality rates and costs across diverse hospitals, offering a new blueprint for emergency care.

With new memberships, Prenuvo aims to standardize proactive MRI screening. Is this the future of health or a high-priced service with unproven benefits?

With over AUD$1M in sales from its first MDMA batch, Cortexa is validating Australia's pioneering move to legalize psychedelic-assisted therapy.

With a new $40M loan, Hyperfine is set to accelerate the rollout of its Swoop® system, bringing AI-powered brain imaging directly to the patient's bedside.

New research reveals a startling link between common liver conditions and heart failure in older adults with atrial fibrillation, urging a new look at risk.

With a new grant, Tessera Therapeutics is advancing its novel Gene Writing platform to engineer a scalable, single-shot cure for HIV. But can it work?

A new one-hour test for sepsis could change critical care, offering rapid results that help doctors fight the clock and save lives. Here's how it works.

Charité, Germany's leading hospital, adopts Coreline Soft's AI, signaling a major shift toward standardized, tech-driven national cancer detection.

A Letter of Support from Siemens Healthineers validates Imaginostics' quest to revolutionize MRI with AI, aiming for earlier, more objective disease detection.

New study shows AI can match invasive methods for plaque analysis, a major step towards non-invasively predicting and preventing heart attacks.

Two industry titans, Sakura Finetek and Hamamatsu Photonics, are teaming up to eliminate critical errors by seamlessly linking slide prep and digital imaging.

A 30-year-old breakthrough could revolutionize physics and cancer detection. Its inventor now demands a public test to prove it, alleging a cover-up.

A landmark UN declaration recognizes oral health as a global priority. Now, health advocates are pushing governments to turn promises into patient care.

Biotech firm Ribo Life Science reveals a new platform targeting the kidney, heart, and fat tissue, signaling a major shift for RNA-based medicines.